Study of the Large-scale Temperature Structure of the Perseus Cluster with Suzaku

We report on a study of the large-scale temperature structure of the Perseus cluster with Suzaku, using the observational data of four pointings of 30' offset regions, together with the data from the central region. Thanks to the Hard X-ray Detector (HXD-PIN: 10 - 60 keV), Suzaku can determine the temperature of hot galaxy clusters. We performed the spectral analysis, by considering the temperature structure and the collimator response of the PIN correctly. As a result, we found that the upper limit of the temperature in the outer region is $\sim$ 14 keV, and an extremely hot gas, which was reported for RXJ 1347.5-1145 and A 3667, was not found in the Perseus cluster. This indicates that the Perseus cluster has not recently experienced a major merger.Comment: 17 pages, 25 figures, accepted for Publications of the Astronomical Society of Japan, references adde

Applications of external fixation in long bone tumor

There has been a dramatic improvement in the survival rate of patients with sarcomas and in the successful salvage of limbs as a result of progress in chemotherapy, radiological evaluation, surgical technique, and the technology of materials and implants. Complications, however, such as deep infection, fracture, bone resorption, and breakages of prostheses still occur. The challenge to provide long-lasting survival and function of the limb after reconstruction is now being met with biological solutions using living bone. The ideal reconstruction should have biological affinity, resistance to infection, sufficient biomechanical strength, and durability. Vascularized bone transfer has limitations in terms of length and strength. Since 1990, distraction osteogenesis, which can regenerate bone of sufficient strength for reconstruction, has been adopted for tumor surgery. © Springer-Verlag Italia 2008, 2012.[Book Chapter

Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: With special reference to electroencephalographic changes

AbstractPurposeEpileptic spasms (ES) beyond infancy are a highly refractory type of seizures that require the development of an effective treatment. We therefore studied the efficacy and safety of topiramate (TPM), which is a drug that is indicated to be effective for intractable childhood epilepsy, for ES.MethodsOut of 58 children with ES, we enrolled 33 patients treated with TPM at ≤12years of age. The administration of TPM was limited to cases of epilepsies that were resistant to any other potent treatment. We retrospectively investigated the efficacy of TPM for seizures and changes in electroencephalogram (EEG) findings.ResultsThe median age at the start of TPM treatment was 5years, 8months. All patients had ES and 28 also had tonic seizures. As for the efficacy of TPM for all seizures, five patients became seizure-free and two had a ≥50% reduction in seizures. Seizure aggravation was observed in six patients. Of 29 patients whose EEG findings were compared before and during TPM treatment, nine showed EEG improvement with reduced epileptic discharges. Adverse effects were observed in 13 patients and included somnolence, anorexia, and irritability. In general, TPM was well tolerated.ConclusionsTPM can be effective at suppressing very intractable ES in a proportion of patients who do not respond to any other treatment. The efficacy of TPM may be predictable based on EEG changes observed early in the course of treatment. TPM is promising for the treatment of extremely intractable childhood epilepsy and it has largely tolerable adverse effects

Tumor-targeting Salmonella typhimurium A1-R prevents experimental human breast cancer bone metastasis in nude mice.

Bone metastasis is a lethal and morbid late stage of breast cancer that is currently treatment resistant. More effective mouse models and treatment are necessary. High bone-metastatic variants of human breast cancer cells were selected in nude mice by cardiac injection. After cardiac injection of a high bone-metastatic variant of breast cancer, all untreated mice had bone metastases compared to only 20% with parental cells. Treatment with tumor-targeting Salmonella typhimurium A1-R completely prevented the appearance of bone metastasis of the high metastatic variant in nude mice (P < 0.001). After injection of the highly bone-metastatic breast cancer variant to the tibia of nude mice, S. typhimurium A1-R treatment significantly reduced tumor growth in the bone (P < 0.001). These data indicated that S. typhimurium A1-R is useful to prevent and inhibit breast cancer bone metastasis and should be of future clinical use for breast cancer in the adjuvant setting

Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R.

Prognosis of patients with lung metastases of soft-tissue sarcoma is still poor. Therefore, novel systemic therapy is needed to improve the survival of soft-tissue sarcoma. In the present study, tumor-targeting therapy with a genetically-modified auxotrophic strain of Salmonella typhimurium, termed A1-R, was evaluated. Mouse models of primary soft tissue sarcoma and spontaneous lung metastasis were obtained by orthotopic intra-muscular injection of HT1080-RFP human fibrosarcoma cells. S. typhimurium A1-R was administered from day 14, once a week for two weeks. On day 28, lung samples were excised and observed with a fluorescence imaging system. The number of lung metastasis was 8.8 ± 3.4 in the untreated group and 0.8 ± 0.8 in the treated group (P = 0.024). A mouse model of experimental lung metastasis was obtained by tail vein injection of HT1080-RFP cells. The mice were treated with S. typhimurium A1-R (i.v.) on day 7, once a week for three weeks. S. typhimurium A1-R significantly reduced lung metastases and improved overall survival (P = 0.004). S. typhimurium A1-R bacterial therapy has future potential for treating advanced soft tissue sarcoma and improving prognosis of patients with lung metastasis